Two Sigma Investments
AMRI

Two Sigma Investments’s Albany Molecular Research Inc AMRI Stock Holding History

Two Sigma Investments’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-132,055
Closed -$2.87M – 3449
2017
Q2 		$2.87M Sell
132,055
-25,805
-16% -$468K 0.01% 1187
2017
Q1 		$2.21M Buy
+157,860
New +$2.59M 0.01% 1398
2016
Q4 		– Sell
-98,075
Closed -$1.62M – 3709
2016
Q3 		$1.62M Buy
98,075
+68,884
+236% +$1.02M 0.01% 1622
2016
Q2 		$392K Sell
29,191
-126,115
-81% -$1.84M ﹤0.01% 2410
2016
Q1 		$2.38M Sell
155,306
-21,732
-12% -$341K 0.01% 1085
2015
Q4 		$3.51M Buy
177,038
+142,867
+418% +$2.72M 0.02% 809
2015
Q3 		$595K Sell
34,171
-80,645
-70% -$1.64M ﹤0.01% 1459
2015
Q2 		$2.32M Buy
+114,816
New +$2.22M 0.01% 1105
2014
Q4 		– Sell
-60,116
Closed -$1.33M – 2488
2014
Q3 		$1.33M Sell
60,116
-77,693
-56% -$1.59M 0.01% 985
2014
Q2 		$2.77M Buy
137,809
+5,467
+4% +$92.6K 0.01% 912
2014
Q1 		$2.46M Buy
132,342
+105,640
+396% +$1.45M 0.01% 867
2013
Q4 		$269K Buy
+26,702
New +$323K ﹤0.01% 1923
2013
Q3 		– Sell
-10,003
Closed -$119K – 2264
2013
Q2 		$119K Buy
+10,003
New +$108K ﹤0.01% 1873

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Two Sigma Investments's AMRI Position: Q3 2017 in Review

Two Sigma Investments sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 132,055 shares — an estimated $2.87M sold.

Two Sigma Investments first reported a position in AMRI in Q2 2013 and held it in 13 quarters. The position peaked at $3.51M in Q4 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Two Sigma Investments reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Two Sigma Investments sold 132,055 Albany Molecular Research Inc shares in Q3 2017, an estimated $2.87M.
  • Two Sigma Investments first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 13 quarters.
  • Two Sigma Investments's Albany Molecular Research Inc position peaked at $3.51M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Two Sigma Investments's 13F filing for Q3 2017, filed 14 Nov 2017.